Pre-order Enquiry
Request Free Sample
Global Biosimilar Drug Market Research Report 2020
SKU ID : QYR-15063817 | Publishing Date : 09-Jan-2020 | No. of pages : 98
Detailed TOC of Global Biosimilar Drug Market Research Report 2020
Table of Contents1 Biosimilar Drug Market Overview
1.1 Product Overview and Scope of Biosimilar Drug
1.2 Biosimilar Drug Segment by Type
1.2.1 Global Biosimilar Drug Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Injection
1.2.3 Tablets
1.2.4 Other Types
1.3 Biosimilar Drug Segment by Application
1.3.1 Biosimilar Drug Sales Comparison by Application: 2020 VS 2026
1.3.2 Ankylosing Spondylitis
1.3.3 Tumor
1.3.4 Rheumatoid Arthrtis
1.3.5 Cardiovascular
1.3.6 Other Application
1.4 Global Biosimilar Drug Market Size Estimates and Forecasts
1.4.1 Global Biosimilar Drug Revenue 2015-2026
1.4.2 Global Biosimilar Drug Sales 2015-2026
1.4.3 Biosimilar Drug Market Size by Region: 2020 Versus 2026
2 Global Biosimilar Drug Market Competition by Manufacturers
2.1 Global Biosimilar Drug Sales Market Share by Manufacturers (2015-2020)
2.2 Global Biosimilar Drug Revenue Share by Manufacturers (2015-2020)
2.3 Global Biosimilar Drug Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Biosimilar Drug Manufacturing Sites, Area Served, Product Type
2.5 Biosimilar Drug Market Competitive Situation and Trends
2.5.1 Biosimilar Drug Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Biosimilar Drug Players (Opinion Leaders)
3 Biosimilar Drug Retrospective Market Scenario by Region
3.1 Global Biosimilar Drug Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Biosimilar Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Biosimilar Drug Market Facts & Figures by Country
3.3.1 North America Biosimilar Drug Sales by Country
3.3.2 North America Biosimilar Drug Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Biosimilar Drug Market Facts & Figures by Country
3.4.1 Europe Biosimilar Drug Sales by Country
3.4.2 Europe Biosimilar Drug Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Biosimilar Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Biosimilar Drug Sales by Region
3.5.2 Asia Pacific Biosimilar Drug Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Biosimilar Drug Market Facts & Figures by Country
3.6.1 Latin America Biosimilar Drug Sales by Country
3.6.2 Latin America Biosimilar Drug Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Biosimilar Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Biosimilar Drug Sales by Country
3.7.2 Middle East and Africa Biosimilar Drug Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Biosimilar Drug Historic Market Analysis by Type
4.1 Global Biosimilar Drug Sales Market Share by Type (2015-2020)
4.2 Global Biosimilar Drug Revenue Market Share by Type (2015-2020)
4.3 Global Biosimilar Drug Price Market Share by Type (2015-2020)
4.4 Global Biosimilar Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Biosimilar Drug Historic Market Analysis by Application
5.1 Global Biosimilar Drug Sales Market Share by Application (2015-2020)
5.2 Global Biosimilar Drug Revenue Market Share by Application (2015-2020)
5.3 Global Biosimilar Drug Price by Application (2015-2020)
6 Company Profiles and Key Figures in Biosimilar Drug Business
6.1 Amgen
6.1.1 Corporation Information
6.1.2 Amgen Description, Business Overview and Total Revenue
6.1.3 Amgen Biosimilar Drug Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Amgen Products Offered
6.1.5 Amgen Recent Development
6.2 Eli Lilly
6.2.1 Eli Lilly Biosimilar Drug Production Sites and Area Served
6.2.2 Eli Lilly Description, Business Overview and Total Revenue
6.2.3 Eli Lilly Biosimilar Drug Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Eli Lilly Products Offered
6.2.5 Eli Lilly Recent Development
6.3 Novartis
6.3.1 Novartis Biosimilar Drug Production Sites and Area Served
6.3.2 Novartis Description, Business Overview and Total Revenue
6.3.3 Novartis Biosimilar Drug Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Novartis Products Offered
6.3.5 Novartis Recent Development
6.4 CP Guojian Pharma
6.4.1 CP Guojian Pharma Biosimilar Drug Production Sites and Area Served
6.4.2 CP Guojian Pharma Description, Business Overview and Total Revenue
6.4.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 CP Guojian Pharma Products Offered
6.4.5 CP Guojian Pharma Recent Development
6.5 Biotech Pharma
6.5.1 Biotech Pharma Biosimilar Drug Production Sites and Area Served
6.5.2 Biotech Pharma Description, Business Overview and Total Revenue
6.5.3 Biotech Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Biotech Pharma Products Offered
6.5.5 Biotech Pharma Recent Development
7 Biosimilar Drug Manufacturing Cost Analysis
7.1 Biosimilar Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Biosimilar Drug
7.4 Biosimilar Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Biosimilar Drug Distributors List
8.3 Biosimilar Drug Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Biosimilar Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Biosimilar Drug by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Biosimilar Drug by Type (2021-2026)
10.2 Biosimilar Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Biosimilar Drug by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Biosimilar Drug by Application (2021-2026)
10.3 Biosimilar Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Biosimilar Drug by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Biosimilar Drug by Region (2021-2026)
10.4 North America Biosimilar Drug Estimates and Projections (2021-2026)
10.5 Europe Biosimilar Drug Estimates and Projections (2021-2026)
10.6 Asia Pacific Biosimilar Drug Estimates and Projections (2021-2026)
10.7 Latin America Biosimilar Drug Estimates and Projections (2021-2026)
10.8 Middle East and Africa Biosimilar Drug Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Biosimilar Drug Market Research Report 2020
List of TablesTable 1. Global Biosimilar Drug Sales (K Dose) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Biosimilar Drug Sales (K Dose) Comparison by Application: 2020 VS 2026
Table 3. Global Biosimilar Drug Market Size by Type (K Dose) (US$ Million) (2020 VS 2026)
Table 4. Global Key Biosimilar Drug Manufacturers Covered in This Study
Table 5. Global Biosimilar Drug Sales (K Dose) by Manufacturers (2015-2020)
Table 6. Global Biosimilar Drug Sales Share by Manufacturers (2015-2020)
Table 7. Global Biosimilar Drug Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Biosimilar Drug Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Biosimilar Drug Average Price (USD/Dose) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Biosimilar Drug Sales Sites and Area Served
Table 11. Manufacturers Biosimilar Drug Product Types
Table 12. Global Biosimilar Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Biosimilar Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Drug as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Biosimilar Drug Players
Table 16. Global Biosimilar Drug Sales (K Dose) by Region (2015-2020)
Table 17. Global Biosimilar Drug Sales Market Share by Region (2015-2020)
Table 18. Global Biosimilar Drug Revenue (Million US$) by Region (2015-2020)
Table 19. Global Biosimilar Drug Revenue Market Share by Region (2015-2020)
Table 20. North America Biosimilar Drug Sales by Country (2015-2020) (K Dose)
Table 21. North America Biosimilar Drug Sales Market Share by Country (2015-2020)
Table 22. North America Biosimilar Drug Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Biosimilar Drug Revenue Market Share by Country (2015-2020)
Table 24. Europe Biosimilar Drug Sales by Country (2015-2020) (K Dose)
Table 25. Europe Biosimilar Drug Sales Market Share by Country (2015-2020)
Table 26. Europe Biosimilar Drug Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Biosimilar Drug Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Biosimilar Drug Sales by Region (2015-2020) (K Dose)
Table 29. Asia Pacific Biosimilar Drug Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Biosimilar Drug Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Biosimilar Drug Revenue Market Share by Region (2015-2020)
Table 32. Latin America Biosimilar Drug Sales by Country (2015-2020) (K Dose)
Table 33. Latin America Biosimilar Drug Sales Market Share by Country (2015-2020)
Table 34. Latin America Biosimilar Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Biosimilar Drug Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Biosimilar Drug Sales by Country (2015-2020) (K Dose)
Table 37. Middle East and Africa Biosimilar Drug Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Biosimilar Drug Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Biosimilar Drug Revenue Market Share by Country (2015-2020)
Table 40. Global Biosimilar Drug Sales (K Dose) by Type (2015-2020)
Table 41. Global Biosimilar Drug Sales Share by Type (2015-2020)
Table 42. Global Biosimilar Drug Revenue (Million US$) by Type (2015-2020)
Table 43. Global Biosimilar Drug Revenue Share by Type (2015-2020)
Table 44. Global Biosimilar Drug Price (USD/Dose) by Type (2015-2020)
Table 45. Global Biosimilar Drug Sales (K Dose) by Application (2015-2020)
Table 46. Global Biosimilar Drug Sales Market Share by Application (2015-2020)
Table 47. Global Biosimilar Drug Sales Growth Rate by Application (2015-2020)
Table 48. Amgen Biosimilar Drug Corporation Information
Table 49. Amgen Description and Business Overview
Table 50. Amgen Biosimilar Drug Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 51. Amgen Main Product
Table 52. Amgen Recent Development
Table 53. Eli Lilly Biosimilar Drug Corporation Information
Table 54. Eli Lilly Corporation Information
Table 55. Eli Lilly Biosimilar Drug Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 56. Eli Lilly Main Product
Table 57. Eli Lilly Recent Development
Table 58. Novartis Biosimilar Drug Corporation Information
Table 59. Novartis Corporation Information
Table 60. Novartis Biosimilar Drug Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 61. Novartis Main Product
Table 62. Novartis Recent Development
Table 63. CP Guojian Pharma Biosimilar Drug Corporation Information
Table 64. CP Guojian Pharma Corporation Information
Table 65. CP Guojian Pharma Biosimilar Drug Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 66. CP Guojian Pharma Main Product
Table 67. CP Guojian Pharma Recent Development
Table 68. Biotech Pharma Biosimilar Drug Corporation Information
Table 69. Biotech Pharma Corporation Information
Table 70. Biotech Pharma Biosimilar Drug Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 71. Biotech Pharma Main Product
Table 72. Biotech Pharma Recent Development
Table 73. Sales Base and Market Concentration Rate of Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Biosimilar Drug Distributors List
Table 76. Biosimilar Drug Customers List
Table 77. Market Key Trends
Table 78. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 79. Key Challenges
Table 80. Global Biosimilar Drug Sales (K Dose) Forecast by Type (2021-2026)
Table 81. Global Biosimilar Drug Sales Market Share Forecast by Type (2021-2026)
Table 82. Global Biosimilar Drug Revenue (Million US$) Forecast by Type (2021-2026)
Table 83. Global Biosimilar Drug Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 84. Global Biosimilar Drug Sales (K Dose) Forecast by Application (2021-2026)
Table 85. Global Biosimilar Drug Revenue (Million US$) Forecast by Application (2021-2026)
Table 86. Global Biosimilar Drug Sales (K Dose) Forecast by Region (2021-2026)
Table 87. Global Biosimilar Drug Sales Market Share Forecast by Region (2021-2026)
Table 88. Global Biosimilar Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 89. Global Biosimilar Drug Revenue Market Share Forecast by Region (2021-2026)
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Biosimilar Drug
Figure 2. Global Biosimilar Drug Sales Market Share by Type: 2020 VS 2026
Figure 3. Injection Product Picture
Figure 4. Tablets Product Picture
Figure 5. Other Types Product Picture
Figure 6. Global Biosimilar Drug Consumption Market Share by Application: 2020 VS 2026
Figure 7. Ankylosing Spondylitis
Figure 8. Tumor
Figure 9. Rheumatoid Arthrtis
Figure 10. Cardiovascular
Figure 11. Other Application
Figure 12. Global Biosimilar Drug Market Size 2015-2026 (US$ Million)
Figure 13. Global Biosimilar Drug Sales Capacity (K Dose) (2015-2026)
Figure 14. Global Biosimilar Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Biosimilar Drug Sales Share by Manufacturers in 2020
Figure 16. Global Biosimilar Drug Revenue Share by Manufacturers in 2019
Figure 17. The Global 5 and 10 Largest Players: Market Share by Biosimilar Drug Revenue in 2019
Figure 18. Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Biosimilar Drug Sales Market Share by Region (2015-2020)
Figure 20. Global Biosimilar Drug Sales Market Share by Region in 2019
Figure 21. Global Biosimilar Drug Revenue Market Share by Region (2015-2020)
Figure 22. Global Biosimilar Drug Revenue Market Share by Region in 2019
Figure 23. North America Biosimilar Drug Sales Market Share by Country in 2019
Figure 24. North America Biosimilar Drug Revenue Market Share by Country in 2019
Figure 25. U.S. Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 26. U.S. Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Canada Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 28. Canada Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. Europe Biosimilar Drug Sales Market Share by Country in 2019
Figure 30. Europe Biosimilar Drug Revenue Market Share by Country in 2019
Figure 31. Germany Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 32. Germany Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. France Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 34. France Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. U.K. Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 36. U.K. Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Italy Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 38. Italy Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Russia Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 40. Russia Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Asia Pacific Biosimilar Drug Sales Market Share by Region in 2019
Figure 42. Asia Pacific Biosimilar Drug Revenue Market Share by Region in 2019
Figure 43. China Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 44. China Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Japan Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 46. Japan Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. South Korea Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 48. South Korea Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. India Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 50. India Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Australia Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 52. Australia Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Taiwan Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 54. Taiwan Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Indonesia Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 56. Indonesia Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Thailand Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 58. Thailand Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Malaysia Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 60. Malaysia Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Philippines Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 62. Philippines Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Vietnam Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 64. Vietnam Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Latin America Biosimilar Drug Sales Market Share by Country in 2019
Figure 66. Latin America Biosimilar Drug Revenue Market Share by Country in 2019
Figure 67. Mexico Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 68. Mexico Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Brazil Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 70. Brazil Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Argentina Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 72. Argentina Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Middle East and Africa Biosimilar Drug Sales Market Share by Country in 2019
Figure 74. Middle East and Africa Biosimilar Drug Revenue Market Share by Country in 2019
Figure 75. Turkey Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 76. Turkey Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Saudi Arabia Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 78. Saudi Arabia Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. U.A.E Biosimilar Drug Sales Growth Rate (2015-2020) (K Dose)
Figure 80. U.A.E Biosimilar Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Sales Market Share of Biosimilar Drug by Type (2015-2020)
Figure 82. Sales Market Share of Biosimilar Drug by Type in 2019
Figure 83. Revenue Share of Biosimilar Drug by Type (2015-2020)
Figure 84. Revenue Market Share of Biosimilar Drug by Type in 2019
Figure 85. Global Biosimilar Drug Sales Growth by Type (2015-2020) (K Dose)
Figure 86. Global Biosimilar Drug Sales Market Share by Application (2015-2020)
Figure 87. Global Biosimilar Drug Sales Market Share by Application in 2019
Figure 88. Global Revenue Share of Biosimilar Drug by Application (2015-2020)
Figure 89. Global Revenue Share of Biosimilar Drug by Application in 2020
Figure 90. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. CP Guojian Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Biotech Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Price Trend of Key Raw Materials
Figure 96. Manufacturing Cost Structure of Biosimilar Drug
Figure 97. Manufacturing Process Analysis of Biosimilar Drug
Figure 98. Biosimilar Drug Industrial Chain Analysis
Figure 99. Channels of Distribution
Figure 100. Distributors Profiles
Figure 101. Porter's Five Forces Analysis
Figure 102. North America Biosimilar Drug Sales (K Dose) and Growth Rate Forecast (2021-2026)
Figure 103. North America Biosimilar Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 104. Europe Biosimilar Drug Sales (K Dose) and Growth Rate Forecast (2021-2026)
Figure 105. Europe Biosimilar Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 106. Latin America Biosimilar Drug Sales (K Dose) and Growth Rate Forecast (2021-2026)
Figure 107. Latin America Biosimilar Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Middle East and Africa Biosimilar Drug Sales (K Dose) and Growth Rate Forecast (2021-2026)
Figure 109. Middle East and Africa Biosimilar Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Asia Pacific Biosimilar Drug Sales (K Dose) and Growth Rate Forecast (2021-2026)
Figure 111. Asia Pacific Biosimilar Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Bottom-up and Top-down Approaches for This Report
Figure 113. Data Triangulation
Figure 114. Key Executives Interviewed
Keyplayers in Global Biosimilar Drug Market Research Report 2020
AmgenEli Lilly
Novartis
CP Guojian Pharma
Biotech Pharma
Request Sample
Request Discount
